Pet DNA Testing Market Size & Growth Forecast 2026–2035, By Segments (Animal Type, Test Type, End-user, Sample Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Pet DNA Testing Market size stood at USD 424.07 Million in 2025 and is predicted to grow at a 9.3% CAGR from 2026 to 2035, exceeding USD 1.03 Billion by 2035. The industry revenue for 2026 is calculated at USD 458.43 million.

• Base Year Value (2025): USD 424.07 Million
• CAGR (2026-2035): 9.3%
• Forecast Year Value (2035): USD 1.03 Billion
• Historical Data Period: 2022-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Pet DNA Testing Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America holds 44.31% share, driven by high pet care spending, strong consumer awareness, veterinary integration of genetic testing, and established e-commerce channels supporting routine adoption.
  • Asia Pacific’s 10.51% CAGR is supported by rising pet ownership, urbanization, premium pet care demand, expanding digital retail access, and growing awareness of breed and health insights.

• Segment Momentum:

  • Dogs lead with 54.66% share due to widespread DNA testing for breed identification, lineage tracking and trait analysis, strongly integrated into adoption, breeding and routine pet care decisions.
  • Health and Wellness is the fastest-growing test type as pet owners increasingly seek preventive care-oriented genetic insights that support individualized health management and awareness of inherited risks.

• Market Expansion Drivers:

  • Rising pet ownership and consumer spending on pet health driving DNA testing adoption.
  • Advancements in affordable genomic sequencing expanding accessibility of at-home pet testing kits.
  • Growing premiumization of pet care and personalized veterinary diagnostics services.

• Leading Market Participants:

  Leading players in the pet DNA testing market include Mars Petcare Inc. (United States), Zoetis Inc. (United States), Embark Veterinary, Inc. (United States), Neogen Corporation (United States), Orivet Genetic Pet Care Limited (Australia), Macrogen, Inc. (South Korea), Genetic Technologies Limited (Australia), DNA My Dog Inc. (Canada), Clinomics Inc. (South Korea).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 424.07 Million
  • Projected Market Size: USD 1.03 Billion by 2035
  • Growth Forecasts: 9.3% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Dogs (Animal Type) | Breed Profile (Test Type) | Breeders (End-user) | Saliva (Sample Type)
  • Emerging Opportunity Segment: Cats (Animal Type) | Health and Wellness (Test Type) | Pet Owners (End-user) | Blood (Sample Type)

Market Growth Drivers and Industry Trends

Rising pet ownership and consumer spending on pet health driving DNA testing adoption

As pet ownership expands and animals are increasingly treated as long-term household companions, spending decisions are shifting from basic care toward preventive and insight-based services. In the pet DNA testing market, this translates into stronger uptake of breed identification, inherited condition screening, and trait analysis kits, especially among owners willing to invest earlier in a pet’s life. The driver works in practice by widening the addressable customer base while also raising willingness to pay for non-essential but decision-shaping health information, aiding market expansion through routine consumer purchasing rather than only veterinarian-led testing.

Advancements in affordable genomic sequencing expanding accessibility of at-home pet testing kits

Lower sequencing costs and more efficient sample processing have made it commercially viable for companies to offer simpler, lower-priced test kits without removing the core value of genetic insight. This is increasing market adoption in the pet DNA testing market by reducing the cost barrier for first-time buyers and enabling direct-to-consumer distribution through e-commerce, pet retail, and subscription-based wellness channels. As accessibility improves, adoption is influenced less by specialist referral and more by convenience, with easy cheek-swab collection and digital result delivery turning pet genetics into a scalable consumer diagnostics category.

Growing premiumization of pet care and personalized veterinary diagnostics services

Premium pet care spending is pushing owners and service providers toward tools that support individualized treatment, nutrition, and wellness decisions rather than standardized care pathways. In the pet DNA testing market, that shift is strengthening market development by positioning genetic testing as part of a broader personalized care model, where results inform breed-specific risk assessment, tailored diet planning, and more targeted veterinary monitoring. The effect is especially visible in higher-value service bundles, as clinics and pet health platforms use DNA insights to differentiate offerings and deepen ongoing customer engagement rather than relying on one-time product sales alone.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising pet ownership and consumer spending on pet health driving DNA testing adoption	2.50%	Low	North America, Europe	High	Near Term
Advancements in affordable genomic sequencing expanding accessibility of at-home pet testing kits	2.30%	Moderate	North America, Asia Pacific	High	Near Term
Growing premiumization of pet care and personalized veterinary diagnostics services	1.90%	Moderate	North America, Europe	High	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held a 44.31% share of the pet DNA testing market in 2025, bolstered by a well-established pet care ecosystem, high consumer willingness to spend on companion animal health, and broad awareness of genetic screening for breed identification, trait analysis, and inherited disease risk. The region’s leadership is reinforced by the practical integration of DNA testing into routine pet ownership decisions, where consumers increasingly use test results to guide nutrition, preventive care, and breeder selection, while veterinary access and developed e-commerce channels help sustain steady test uptake.

Asia Pacific is projected to expand at a 10.51% CAGR over the forecast period, with momentum in the pet DNA testing market being impelled by rising pet ownership, increasing urbanization, and growing consumer interest in premium pet care services. Growth is accelerating as more pet owners in the region move beyond basic care toward data-driven health and wellness decisions, creating stronger adoption for genetic testing in areas such as breed verification and early health insight, particularly as access improves through digital retail platforms and expanding pet services infrastructure.

Key Country Insights

United States

Consumer Genomics Adoption

The U.S. pet DNA testing market benefits from strong consumer interest in breed identification, inherited health screening, and personalized pet care. Companies continue expanding genomic databases and veterinary partnerships to enhance testing accuracy and service offerings.

Japan

Companion Animal Wellness

Japan's growing focus on companion animal health supports demand for pet DNA testing services. Providers emphasize user-friendly testing solutions that deliver breed information and actionable genetic health insights for pet owners and veterinarians.

South Korea

Digital Pet Care Integration

South Korea is incorporating pet DNA testing into a broader digital pet healthcare ecosystem. Service providers combine genetic analysis with mobile health platforms and personalized wellness recommendations to improve long-term pet management.

Germany

Preventive Pet Genetics

Germany is integrating pet DNA testing into preventive veterinary care and responsible breeding practices. Pet owners increasingly seek genetic insights that support early health management and informed long-term care decisions.

France

Responsible Breeding Support

France utilizes pet DNA testing to strengthen responsible breeding practices and improve hereditary disease awareness. Veterinary professionals and breeders increasingly value reliable genetic screening that supports informed breeding and healthcare decisions.

Italy

Personalized Veterinary Insights

Italy is seeing greater adoption of pet DNA testing as owners seek individualized health information for companion animals. Market participants focus on accessible testing services that help veterinarians tailor preventive care and breed-specific health management.

Segment Leadership and Growth Trends

  Animal Type Segment Analysis: Dogs (Largest Segment) vs Cats (Fastest-Growing Segment)

Dogs held the leading position in the pet DNA testing market in 2025, accounting for a 54.66% share. This leadership is underpinned by the broad use of DNA testing among dog owners for breed identification, lineage understanding, and trait assessment, all of which have direct relevance in adoption, breeding, and routine pet care decisions. The dog segment also benefits from a wider established testing base, as canine genetic testing has been more commercially visible and operationally integrated into consumer pet services than other animal categories in the pet DNA testing market.

Cats are emerging as the fastest-growing segment in the pet DNA testing market as owners show rising interest in genetic insights that go beyond basic identification and support more informed care decisions. Growth is being encouraged by increasing awareness that feline DNA testing can help clarify breed background, inherited traits, and selected health-related considerations in a category that has historically seen lower testing penetration than dogs. Relative to alternatives, the cats segment is gaining momentum because it is expanding from a smaller installed base, leaving more room for adoption as testing relevance becomes clearer to cat owners.

Test Type Segment Analysis: Breed Profile (Largest Segment) vs Health and Wellness (Fastest-Growing Segment)

Within the pet DNA testing market, Breed Profile remained the largest test type in 2025 with a 40.35% share. Its leading position is aided by strong consumer demand for straightforward answers about a pet’s breed composition, especially among mixed-breed animals where background is unknown. Breed Profile testing maintains broad appeal because it offers immediate and easily understood value to owners, helping explain physical traits and behavioral tendencies while serving as the most accessible entry point into the pet DNA testing market.

Health and Wellness is the fastest-growing test type in the pet DNA testing market because owners are increasingly looking for genetic information that can support ongoing care choices rather than one-time breed discovery alone. This segment is gaining momentum as pet care decisions become more preventive and individualized, creating stronger demand for tests that inform everyday wellness management and potential inherited risk awareness. Compared with Breed Profile, Health and Wellness is growing faster because it aligns more directly with evolving owner expectations for practical, care-oriented genetic insight.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Animal Type	Dogs, Cats, Others	Dogs	Cats
Test Type	Breed Profile, Genetic Diseases, Health and Wellness	Breed Profile	Health and Wellness
End-user	Pet Owners, Breeders, Veterinarians	Breeders	Pet Owners
Sample Type	Blood, Saliva, Fecal, Others	Saliva	Blood

Competitive Landscape and Market Positioning

Key companies in the pet DNA testing market:

1. Mars Petcare Inc. (United States)

2. Zoetis Inc. (United States)

3. Embark Veterinary Inc. (United States)

4. Neogen Corporation (United States)

5. Orivet Genetic Pet Care Limited (Australia)

6. Macrogen Inc. (South Korea)

7. Genetic Technologies Limited (Australia)

8. DNA My Dog Inc. (Canada)

9. Clinomics Inc. (South Korea)

The pet DNA testing market is expanding as pet owners increasingly seek insights into genetic traits and health predispositions. Advances in genomic analysis are improving testing accuracy and result interpretation. New service offerings are enabling more detailed breed and health profiling. The pet DNA testing market continues to evolve with rising demand for personalized pet healthcare insights.

Industry Development/News

Company Name	Date	Key Development
Mars	Jul-24	Mars completed the acquisition of Cerba Vet and Antagene, expanding its veterinary diagnostics and animal DNA testing capabilities in France. The acquisition enhances Mars’ position in pet genomics and veterinary diagnostics by integrating laboratory infrastructure and specialized DNA testing services for companion animal health and genetic disease identification.
The Kennel Club	Feb-25	The Kennel Club introduced two DNA testing schemes targeting gangliosidosis (GM1_2 and GM2_2) in Japanese Shiba Inu dogs. The initiative supports genetic screening to identify carriers and affected dogs, strengthening breeding program accuracy and contributing to the reduction of inherited neurological diseases in purebred populations.
DNA My Dog	Jan-25	DNA My Dog partnered with DreamWorks Animation’s Dog Man franchise to launch a sweepstakes integrating pet DNA testing with entertainment engagement. The initiative aims to increase consumer awareness of breed identification testing while enhancing customer acquisition through cross-industry promotional collaboration.
University of Cambridge & Wisdom Panel	Aug-24	Researchers at the University of Cambridge, supported by Wisdom Panel, developed a DNA test aimed at eliminating progressive retinal atrophy in English Shepherd Dogs. The development advances genetic screening tools for inherited disease prevention and supports improved selective breeding strategies in companion animal populations.
Ancestry	Sep-23	Ancestry launched its first pet DNA testing product, “Know Your Pet DNA,” expanding beyond human ancestry testing into the companion animal genomics segment. The move diversifies its product portfolio and establishes entry into the growing consumer pet genetics market.
Embark Veterinary	Oct-21	Embark Veterinary launched a DNA test designed for purebred dogs, expanding its canine genetics portfolio. The product strengthens its competitive positioning in pet genomics by offering targeted breed-specific genetic insights for health, lineage, and disease risk assessment.